Shahad W. Kattan

Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway

Shahad W. Kattan, Mohamed S. Nafie, Gamal A. Elmgeed et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2020 · 73 citations

Medicine, Oncology, Pharmacology +17

Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival

Shahad W. Kattan, Yahya Hobani, Sameerah Shaheen et al. · Cellular & Molecular Biology Letters · 2021 · 33 citations · Full text

Life Sciences, Genetics, Oncology +17

Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy

Hala M.F. Mohammad, Ahmed A. Abdelghany, Essam Al Ageeli et al. · Pharmacogenomics and Personalized Medicine · 2021 · 19 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Cytotoxicity, <i>in silico</i> predictions and molecular studies for androstane heterocycle compounds revealed potential antitumor agent against lung cancer cells

Mohamed A. Tantawy, Sameerah Shaheen, Shahad W. Kattan et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids

Roya Babaei‐Jadidi, Hossein Kashfi, Walla Alelwani et al. · Oncogenesis · 2022 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17